We are live on ! Find out more
DU

Delphia (USA) Portfolio holdings

AUM $445K
1-Year Est. Return 28.82%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+28.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.1M
AUM Growth
–
Cap. Flow
+$93.3M
Cap. Flow %
99.2%
Top 10 Hldgs %
16.04%
Holding
264
New
264
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.69M
2
MSFT icon
Microsoft
MSFT
+$2.31M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.05M
4
META icon
Meta Platforms (Facebook)
META
+$1.38M
5
AMZN icon
Amazon
AMZN
+$1.26M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 20.72%
2 Healthcare 15.9%
3 Consumer Discretionary 12.95%
4 Communication Services 8.88%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VVNT
251
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$105K 0.11%
+10,785
New +$106K
RYAM icon
252
Rayonier Advanced Materials
RYAM
$621M
$104K 0.11%
+18,215
New +$118K
DSKE
253
DELISTED
Daseke, Inc. Common Stock
DSKE
$101K 0.11%
+10,031
New +$98.6K
PBI icon
254
Pitney Bowes
PBI
$2.47B
$100K 0.11%
+15,042
New +$107K
CRD.A icon
255
Crawford & Co Class A
CRD.A
$613M
$97K 0.1%
+13,003
New +$107K
MRC
256
DELISTED
MRC Global
MRC
$88K 0.09%
+12,834
New +$100K
RLGT icon
257
Radiant Logistics
RLGT
$396M
$78K 0.08%
+10,664
New +$76.7K
SXC icon
258
SunCoke Energy
SXC
$817M
$72K 0.08%
+10,990
New +$72.9K
DNTH icon
259
Dianthus Therapeutics
DNTH
$6.04B
$68K 0.07%
+962
New +$96.7K
MTEM
260
DELISTED
Molecular Templates, Inc.
MTEM
$67K 0.07%
+1,139
New +$85.3K
CGEN icon
261
Compugen
CGEN
$218M
$64K 0.07%
+14,791
New +$80K
VKTX icon
262
Viking Therapeutics
VKTX
$3.87B
$62K 0.07%
+13,468
New +$75.5K
SYRE icon
263
Spyre Therapeutics
SYRE
$9.01B
$61K 0.06%
+518
New +$81.8K
FBRX icon
264
Forte Biosciences
FBRX
$1.57B
$33K 0.04%
+610
New +$41K
7 8 9 10
11

Similar funds

QTM
qPULA Trading Management New York $289K AUM 0% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
WM
Wyrmwood Management New York $104K AUM
GIFI
Gemini Israel Funds IV Herzliya, Israel $46K AUM
UVM
Upfront Ventures Management Santa Monica, California $12.3K AUM
BRA
Blue Rock Advisors Wayzata, Minnesota $7K AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Delphia (USA)'s Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Delphia (USA), which disclosed 264 positions worth $94.1M. Its ten largest holdings account for 16% of the portfolio.

Its largest position is Apple: 17,013 shares worth $3.02M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, followed by Healthcare and Consumer Discretionary.

  • Delphia (USA)'s largest Q4 2021 buy was Apple: 17,013 shares worth $3.02M.
  • Delphia (USA)'s ten largest holdings make up 16% of its $94.1M portfolio in Q4 2021.
  • Delphia (USA) disclosed 264 positions in Q4 2021, its first 13F filing on record.

Based on Delphia (USA)'s 13F filing for Q4 2021, filed 14 Feb 2022.